Study of STA-1 as an Add-on Treatment to Donepezil

NCT01255046 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Donepezil,
DRUG: STA-1
DRUG: placebo

Sponsor

Sinphar Pharmaceutical Co., Ltd